Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has provided an update.
MedPlus Health Services Ltd. has disclosed that its subsidiary, Optival Health Solutions Private Limited, received a one-day suspension of the drug license for a pharmacy located in Kuntloor, Telangana. The suspension was ordered by the Assistant Director of the Drugs Control Administration, Rangareddy, under Rule 65 of the Drugs and Cosmetics Act, 1940, and associated rules.
The company estimates the financial impact of this regulatory action as a potential revenue loss of Rs 0.42 lakh, indicating a limited effect on overall operations. MedPlus has made the details of the order available on its website and through the BSE and NSE disclosures, signaling transparency to investors and other stakeholders regarding compliance-related developments.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare and pharmaceutical retail sector in India, primarily through its network of pharmacies and related health service outlets. The company serves urban and semi-urban markets, offering prescription drugs, over-the-counter medicines, and health products to a broad consumer base.
Average Trading Volume: 15,196
Technical Sentiment Signal: Strong Buy
Current Market Cap: 101.7B INR
Find detailed analytics on MEDPLUS stock on TipRanks’ Stock Analysis page.